Antineoplastic agent (specifically a monoclonal antibody) Medicines in UAE
289 medicines available
About Antineoplastic agent (specifically a monoclonal antibody) Medicines
This page lists all Antineoplastic agent (specifically a monoclonal antibody) medicines available in UAE pharmacies.
Click on any medicine name to view detailed information including uses, dosage, side effects, and availability.
Complete List of Antineoplastic agent (specifically a monoclonal antibody) Medicines
Brand: AZD or AZD/EVU |
Strength: 100 Or 150 mg/mL |
Form: Solution For Injection
Class: | Antineoplastic agent (specifically a monoclonal antibody)
Use: | Treatment of certain types of cancer, including but not limited to non-small cell lung cancer (NSCLC) and other solid tumors...
Class: | Monoclonal antibody (long-acting neutralizing antibody combination)
Use: | Prevention of COVID-19 in individuals at high risk of exposure or severe disease
Adult dose: | 600 mg administer...
Class: | Monoclonal antibody (IgG1)
Use: | Treatment of Alzheimer's disease in patients with confirmed presence of amyloid beta plaques
Adult dose: | 10 mg/kg administered as an intravenous infusi...
Class: | Monoclonal antibody (anti-amyloid beta)
Use: | Treatment of Alzheimer's disease in patients with confirmed presence of amyloid beta pathology
Adult dose: | 10 mg/kg administered as an int...
Class: | Monoclonal antibody (anti-CD52)
Use: | Treatment of relapsing forms of multiple sclerosis (MS) in adults
Adult dose: | Initial dose: 12 mg IV on days 1, 3, 5, 12, and 24 of the first year...
Brand: LEMTRADA |
Strength: 12 mg/1.2ml |
Form: Solution For Iv Injection
Class: | Monoclonal antibody (anti-CD52)
Use: | Treatment of relapsing forms of multiple sclerosis (MS) in adults
Adult dose: | 12 mg IV on two separate treatment days (first dose on Day 1 and sec...
Class: | Monoclonal antibody
Use: | Alemtuzumab is primarily used for the treatment of B-cell chronic lymphocytic leukemia (B-CLL) in patients who have been treated with alkylating agents and have fai...
Class: | Monoclonal antibody (anti-CD52)
Use: | Treatment of relapsing forms of multiple sclerosis (MS) and chronic lymphocytic leukemia (CLL)
Adult dose: | 12 mg IV on days 1, 2, 3, and 4 of the ...
Class: | Monoclonal antibody (EGFR and MET inhibitor)
Use: | Treatment of adult patients with non-small cell lung cancer (NSCLC) that is positive for epidermal growth factor receptor (EGFR) exon 20 ...
Brand: Rybrevant |
Strength: 350 mg/1Vial |
Form: Concentrate For Solution For Infusion
Class: | Monoclonal antibody (EGFR and MET inhibitor)
Use: | Treatment of adult patients with non-small cell lung cancer (NSCLC) that is positive for epidermal growth factor receptor (EGFR) exon 20 ...
Brand: Saphnelo |
Strength: 300 mg/1 vial |
Form: Concentrate For Solution For Infusion
Class: | Monoclonal antibody (IgG1κ)
Use: | Treatment of moderate to severe systemic lupus erythematosus (SLE) in adults
Adult dose: | 300 mg administered as an intravenous infusion every 4 weeks ...
Brand: TECENTRIQ |
Strength: 1200 mg |
Form: Concentrate For Solution For Infusion
Class: | Monoclonal antibody (PD-L1 inhibitor)
Use: | Treatment of locally advanced or metastatic urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), and ...
Class: | Monoclonal antibody (PD-L1 inhibitor)
Use: | Treatment of locally advanced or metastatic urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), and ...
Brand: TECENTRIQ |
Strength: 840 mg |
Form: Powder for Concentrate for Solution for Infusion.
Class: | Monoclonal antibody (PD-L1 inhibitor)
Use: | Treatment of locally advanced or metastatic urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer, and other m...
Brand: TECENTRIQ |
Strength: 840 mg |
Form: Powder for Concentrate for Solution for Infusion.
Class: | Monoclonal antibody (PD-L1 inhibitor)
Use: | Treatment of locally advanced or metastatic urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), and ...
Brand: BAVENCIO |
Strength: 20 mg/ml |
Form: Concentrate For Dilution For Infusion
Class: | Monoclonal antibody (PD-L1 inhibitor)
Use: | Treatment of metastatic Merkel cell carcinoma (MCC) in adults and pediatric patients, and treatment of locally advanced or metastatic urothelial...
Class: | Monoclonal antibody (IgG1)
Use: | Treatment of mild to moderate COVID-19 in patients at high risk for progression to severe disease and/or hospitalization
Adult dose: | 700 mg administere...
Class: | Monoclonal antibody (IL-2 receptor antagonist)
Use: | Prevention of acute rejection in kidney transplantation
Adult dose: | 20 mg IV on the day of transplantation and 4 days post-transpla...
Brand: BENLYSTA |
Strength: 120 mg/Vial |
Form: Powder For Solution For Intravenous Injection
Class: | Monoclonal antibody (B-lymphocyte stimulator (BLyS) inhibitor)
Use: | Treatment of systemic lupus erythematosus (SLE) in adults and pediatric patients aged 5 years and older; treatment of a...
Class: | Monoclonal antibody (B-lymphocyte stimulator (BLyS) inhibitor)
Use: | Treatment of systemic lupus erythematosus (SLE) in adults and children aged 5 years and older; treatment of active lupu...
Brand: BENLYSTA |
Strength: 400 mg/Vial |
Form: Powder For Solution For Intravenous Injection
Class: | Monoclonal antibody (B-lymphocyte stimulator inhibitor)
Use: | Treatment of systemic lupus erythematosus (SLE) in adults and children aged 5 years and older; treatment of active lupus nephr...
Class: | Monoclonal antibody (anti-IL-5 receptor alpha)
Use: | Treatment of severe asthma with eosinophilic phenotype, and for the treatment of chronic rhinosinusitis with nasal polyps in adults
A...
Class: | Monoclonal antibody (anti-IL-5 receptor alpha)
Use: | Indicated for the treatment of severe asthma with eosinophilic phenotype in patients aged 12 years and older, as well as for the treatm...
Class: | Monoclonal antibody (anti-IL-5 receptor alpha)
Use: | Indicated for the treatment of severe asthma with eosinophilic phenotype in patients aged 12 years and older, and for the treatment of ...
Class: | Monoclonal antibody (IL-17A and IL-17F inhibitor)
Use: | Treatment of moderate to severe plaque psoriasis in adults and treatment of active psoriatic arthritis in adults
Adult dose: | Ini...